G
Gary M. Brittenham
Researcher at Columbia University
Publications - 262
Citations - 17412
Gary M. Brittenham is an academic researcher from Columbia University. The author has contributed to research in topics: Anemia & Iron deficiency. The author has an hindex of 62, co-authored 252 publications receiving 16156 citations. Previous affiliations of Gary M. Brittenham include Columbia University Medical Center & MetroHealth.
Papers
More filters
Journal Article
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility. Authors' reply
T. G. St. Pierre,Roland Fischer,Rainer Engelhardt,Gary M. Brittenham,David G. Nathan,Nancy F. Olivieri,J. Pippard,David J. Weatherall,Dudley J. Pennell,Martin Bland,George J. Kontoghiorghes,A. Kolnagou +11 more
Journal ArticleDOI
Isotopic measurement of iron requirements in sub-Saharan African children.
Cornelia Speich,Gary M. Brittenham,Colin I. Cercamondi,Christophe Zeder,Thandile Nkosi-Gondwe,Kamija S. Phiri,Diego Moretti,Diego Moretti,Michael B. Zimmermann +8 more
TL;DR: In this paper, the authors measured long-term iron absorption and iron loss in a 2-y observational study in Malawian children (n = 48) using a novel stable iron isotope method.
Journal ArticleDOI
Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia [see comments]
Victor R. Gordeuk,Philip E. Thuma,Gary M. Brittenham,Stenford Zulu,G Simwanza,A Mhangu,G Flesch,Dean Parry +7 more
TL;DR: In a randomized, double-blind, placebo-controlled crossover trial with 28 volunteers with asymptomatic Plasmodium falciparum infection, desferrioxamine B was significantly greater than placebo (P less than.006) during both the initial and crossover periods.
Impact of the lipophilicity of desferrithiocin analogues on iron clearance
Raymond J. Bergeron,Jan Wiegand,James S. McManis,William R. Weimar,Jeong-Hyun Park,Eileen Eiler-McManis,Jennifer Bergeron,Gary M. Brittenham +7 more
TL;DR: A number of the title compounds synthesized and tested in the laboratory are shown to be both inhibitors of the iron-mediated oxidation of ascorbate as well as effective radical scavengers.